Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Disease Progression × pembrolizumab × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Sarcoma 1 Other solid neoplasm 1

Conditions

Sarcoma 36 Melanoma 15 Neoplasms 11 Squamous Cell Carcinoma of Head and Neck 9 Neoplasm Metastasis 8 Carcinoma, Non-Small-Cell Lung 8 Breast Neoplasms 8 Triple Negative Breast Neoplasms 7 Glioblastoma 7 Pancreatic Neoplasms 6 Ovarian Neoplasms 6 Lung Neoplasms 6 Histiocytoma, Malignant Fibrous 6 Gliosarcoma 6 Colorectal Neoplasms 6 Head and Neck Neoplasms 5 Carcinoma, Renal Cell 5 Carcinoma, Hepatocellular 5 Sarcoma, Synovial 4 Sarcoma, Kaposi 4 Osteosarcoma 4 Lymphoma 4 Liposarcoma 4 Hemangiosarcoma 4 Carcinoma, Merkel Cell 4 Uterine Cervical Neoplasms 3 Urinary Bladder Neoplasms 3 Neurofibrosarcoma 3 Lymphoma, Non-Hodgkin 3 Kidney Neoplasms 3

Interventions

vandetanib 1 pembrolizumab 1 pazopanib 1 nilotinib 1 abexinostat 1 Standard of Care 1 Practice Guidelines as Topic 1 Palliative Care 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03469804 2019-10-21

KAPKEY

Assistance Publique - Hôpitaux de Paris

Phase 2 Unknown

Sarcoma, Kaposi, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon ⚡